Novavax, Inc. (NVAX)
9.99
+0.10
(+1.01%)
USD |
NASDAQ |
Mar 05, 16:00
9.98
-0.01
(-0.10%)
After-Hours: 07:34
Novavax Cash from Investing (Quarterly) : 20.48M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -11.20B |
| Pfizer Inc. | -6.146B |
| Moderna, Inc. | -48.00M |
| Intellia Therapeutics, Inc. | 27.53M |
| Recursion Pharmaceuticals, Inc. | -1.244M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -39.48M |
| Cash from Financing (Quarterly) | -6.604M |
| Free Cash Flow | -251.02M |
| Free Cash Flow Per Share (Quarterly) | -0.2526 |
| Free Cash Flow to Equity (Quarterly) | -68.63M |
| Free Cash Flow to Firm (Quarterly) | -36.02M |
| Free Cash Flow Yield | -14.73% |